hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways
Cited by 0
Related Papers
SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21<sup>CIPI</sup>, cyclin D1 and β‐catenin
|FEBS Open Bio|2019|24
Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
|Frontiers in Pharmacology|2021|13
Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling
|Frontiers in Pharmacology|2022|9